Brookline, MA, United States of America

Frederic Zecri

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 111(Granted Patents)


Location History:

  • Bartenheim, FR (2010 - 2011)
  • Brookline, MA (2017)
  • Cambridge, MA (US) (2018 - 2022)
  • Brookline, MA (US) (2015 - 2023)

Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: Frederic Zecri: A Pioneer in Biochemical Innovations

Introduction

Frederic Zecri is an accomplished inventor based in Brookline, MA, recognized for his contributions to the field of biochemistry and biotechnology. With 27 patents to his name, he has made significant strides in the development of innovative therapeutic solutions.

Latest Patents

Among his latest patents are notable inventions including a conjugate that comprises a biomolecule linked to a fatty acid via a linker. This invention utilizes fatty acids represented by specific formulae and aims to provide enhanced therapeutic options. In addition, his work includes a patent concerning nucleic acids with modifications at both the 5'-end and 3'-end, which results in improved expression, lower immunogenicity, and enhanced stability compared to unmodified nucleic acids. These advancements reflect his commitment to innovation in biomedicine.

Career Highlights

Frederic Zecri is currently associated with Novartis AG, a prominent global healthcare company. His work at Novartis focuses on expanding the potential of therapeutic agents and advancing biotechnological research, demonstrating the synergy between practical applications and scientific inquiry.

Collaborations

Throughout his career, Frederic has collaborated with esteemed colleagues such as Jun Yuan and Hongjuan Zhao. These partnerships underscore the collaborative nature of innovation within the scientific community, facilitating the sharing of ideas and expertise to drive forward-thinking solutions.

Conclusion

Frederic Zecri’s contributions to the field of biochemistry through his 27 patents exemplify his innovative spirit and dedication to improving health outcomes. His work at Novartis AG highlights the importance of collaboration and continual advancement in the field, paving the way for future breakthroughs in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…